Entering text into the input field will update the search result below

OPKO Health's (OPK) CEO Phillip Frost on Q4 2017 Results - Earnings Call Transcript

Mar. 01, 2018 9:37 PM ETOPKO Health, Inc. (OPK)24 Comments
SA Transcripts profile picture
SA Transcripts

OPKO Health, Inc. (NASDAQ:OPK) Q4 2017 Earnings Conference Call March 1, 2018 4:30 PM ET


Anne Marie Fields - Senior Vice President, LHA

Phillip Frost - Chairman and Chief Executive Officer

Steven Rubin - Executive Vice President, Administration

Adam Logal - Vice President and Chief Financial Officer

David Okrongly - President of Diagnostics Business Unit

Thomas Nusbickel - Chief Commercial Officer

Charles Todd - Executive Vice President of Sales and Marketing, BioReference


Louise Chen - Cantor Fitzgerald & Co.

Yale Jen - Laidlaw & Company

Eric Joseph - JPMorgan Chase & Co.

Kevin DeGeeter - Ladenburg Thalmann

Michael Petusky - Barrington Research


Welcome to the OPKO Health Incorporated Business Update Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we'll hold a Q&A session. [Operator Instructions] As a reminder, this conference is being recorded Thursday, March 1, 2018.

I would now like to turn the conference over to Anne Marie Fields. Please go ahead, ma'am.

Anne Marie Fields

Thank you, operator. Good afternoon. This is Anne Marie Fields with LHA Investor Relations. Thank you all for joining today's call. I'd like to remind you that any statements made during this call other than statements of historical fact will be considered forward-looking and as such will be subject to risks and uncertainties that could materially affect the Company's expected results. Those forward-looking statements include, without limitation, the various risks described in the Company's Annual Report on Form 10-K for the year ended December 31, 2017 as filed this afternoon.

Before we begin, let me review the format for today's call. Dr. Phillip Frost, Chairman and Chief Executive Officer will open the call, followed by Steve Rubin, OPKO's Executive Vice President who will provide an update on the Company's various businesses and clinical programs. After that Adam Logal, OPKO's Chief

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.